Deepali S Rajguru, MD
Ophthalmology · Milpitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Rajguru’s office at (408) 945-2900 to ask if they take your plan before you enroll.
California Medical Board record
Licence A92811 · Current
Licensed to practise in California · since 2005 · expires 2027-07-31 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,802
Medicare paid this office $1,802 for 16 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
16 Original Medicare patients in 2024. Average age 70 · Health risk score 1.36. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
The office billed $6,544, Medicare allowed $2,916 and paid $1,802; for 25 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 16 | 25 | 70 | 1.36 | $6,544 | $1,802 |
| 2022 | 16 | 28 | 71 | 0.92 | $9,314 | $1,803 |
| 2020 | 11 | 18 | 68 | 2.00 | $5,022 | $1,391 |
| 2019 | 19 | 31 | 72 | 2.02 | $8,783 | $2,174 |
| 2018 | 16 | 19 | 74 | 2.83 | $4,829 | $1,468 |
| 2017 | 11 | 20 | 80 | 1.42 | $4,042 | $1,037 |
| 2013 | 13 | 14 | 69 | 1.21 | $9,371 | $2,214 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$3,872 in 2024
Medicaid paid $3,872 for 54 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 29 | $1,939 |
| Short return visit | 25 | $1,933 |
| 2024 | 54 | 2 | 16 | $3,872 |
Drugs they prescribed that Part D paid
$82,026
Pharmacies billed $82,026 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,517) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
1,243 generic and 274 brand-name prescriptions · $82,026 in drug cost · 21 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rhopressa | 21 | $12,993 | $619 |
| Brinzolamide | 31 | $7,912 | $255 |
| Latanoprost | 513 | $7,774 | $15 |
| Prednisolone Acetate | 120 | $6,098 | $51 |
| Cyclosporine | 48 | $6,036 | $126 |
See all 19 drugs
| Rhopressa | 21 | $12,993 | $619 |
| Brinzolamide | 31 | $7,912 | $255 |
| Latanoprost | 513 | $7,774 | $15 |
| Prednisolone Acetate | 120 | $6,098 | $51 |
| Cyclosporine | 48 | $6,036 | $126 |
| Fluorometholone | 38 | $4,297 | $113 |
| Dorzolamide-Timolol | 155 | $3,871 | $25 |
| Brimonidine | 95 | $2,366 | $25 |
| Dorzolamide-Timolol | 21 | $1,780 | $85 |
| Timolol Maleate | 92 | $1,530 | $17 |
| Travoprost | 24 | $1,467 | $61 |
| Dorzolamide | 49 | $1,200 | $24 |
| Erythromycin | 74 | $1,088 | $15 |
| Neomycin-Polymyxin-Dexameth | 64 | $806 | $13 |
| Valacyclovir | 12 | $693 | $58 |
| Ketorolac Tromethamine | 25 | $571 | $23 |
| Levobunolol | 11 | $568 | $52 |
| Diclofenac | 36 | $453 | $13 |
| Doxycycline Monohydrate | 14 | $439 | $31 |
Year by year
| 2024 | 1,517 | 493 | 0% (0) | 18% | $82,026 |
| 2023 | 1,443 | 480 | 0% (0) | 19% | $65,957 |
| 2022 | 1,502 | 470 | 0% (0) | 28% | $87,285 |
| 2021 | 1,647 | 496 | 0% (0) | 26% | $112,263 |
| 2020 | 1,562 | 461 | 0% (0) | 20% | $99,880 |
| 2019 | 1,559 | 483 | 0% (0) | 22% | $104,302 |
| 2018 | 1,196 | 459 | 0% (0) | 29% | $93,270 |
| 2017 | 1,222 | 489 | 0% (0) | 37% | $86,949 |
| 2016 | 840 | 301 | 0% (0) | 45% | $63,416 |
| 2015 | 1,369 | 463 | 0% (0) | 51% | $94,497 |
| 2014 | 1,381 | 427 | 0% (0) | 56% | $87,676 |
| 2013 | 1,075 | 433 | None | 57% | $61,142 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Prednisolone Acetate | 157 | $8,430 | $54 |
| Latanoprost | 493 | $7,624 | $15 |
| Cyclosporine | 41 | $6,036 | $147 |
| Rhopressa | 11 | $5,611 | $510 |
| Dorzolamide-Timolol | 137 | $3,645 | $27 |
| Fluorometholone | 25 | $2,744 | $110 |
| Dorzolamide-Timolol | 19 | $2,241 | $118 |
| Dorzolamide | 60 | $1,588 | $26 |
| Timolol Maleate | 91 | $1,570 | $17 |
| Travoprost | 21 | $1,314 | $63 |
| Brimonidine | 78 | $1,168 | $15 |
| Olopatadine | 44 | $1,027 | $23 |
| Erythromycin | 57 | $912 | $16 |
| Levobunolol | 15 | $732 | $49 |
| Neomycin-Polymyxin-Dexameth | 48 | $602 | $13 |
| Doxycycline Monohydrate | 15 | $529 | $35 |
| Ketorolac Tromethamine | 25 | $453 | $18 |
| Diclofenac | 28 | $360 | $13 |
2022: 19 drugs
| Cequa | 22 | $12,793 | $581 |
| Prednisolone Acetate | 240 | $12,387 | $52 |
| Latanoprost | 481 | $8,133 | $17 |
| Rhopressa | 23 | $7,839 | $341 |
| Cyclosporine | 15 | $3,546 | $236 |
| Dorzolamide-Timolol | 135 | $3,485 | $26 |
| Timolol Maleate | 112 | $2,914 | $26 |
| Brimonidine | 65 | $2,252 | $35 |
| Fluorometholone | 14 | $1,884 | $135 |
| Dorzolamide | 62 | $1,653 | $27 |
| Travoprost | 18 | $1,299 | $72 |
| Olopatadine | 53 | $1,240 | $23 |
| Levobunolol | 15 | $815 | $54 |
| Doxycycline Monohydrate | 21 | $681 | $32 |
| Valacyclovir | 11 | $620 | $56 |
| Neomycin-Polymyxin-Dexameth | 40 | $509 | $13 |
| Diclofenac | 31 | $485 | $16 |
| Ketorolac Tromethamine | 24 | $372 | $15 |
| Erythromycin | 25 | $351 | $14 |
2021: 17 drugs
| Prednisolone Acetate | 259 | $19,807 | $76 |
| Cequa | 30 | $17,915 | $597 |
| Latanoprost | 485 | $8,074 | $17 |
| Rhopressa | 21 | $7,688 | $366 |
| Timolol Maleate | 129 | $4,545 | $35 |
| Brimonidine | 94 | $4,335 | $46 |
| Dorzolamide-Timolol | 136 | $4,119 | $30 |
| Fluorometholone | 25 | $3,219 | $129 |
| Travoprost | 16 | $2,684 | $168 |
| Dorzolamide | 47 | $1,300 | $28 |
| Olopatadine | 86 | $1,298 | $15 |
| Levobunolol | 15 | $795 | $53 |
| Doxycycline Monohydrate | 20 | $723 | $36 |
| Ketorolac Tromethamine | 37 | $716 | $19 |
| Erythromycin | 45 | $633 | $14 |
| Neomycin-Polymyxin-Dexameth | 44 | $552 | $13 |
| Diclofenac | 36 | $551 | $15 |
2020: 19 drugs
| Restasis | 40 | $30,931 | $773 |
| Latanoprost | 506 | $9,494 | $19 |
| Prednisolone Acetate | 174 | $9,086 | $52 |
| Dorzolamide-Timolol | 133 | $4,677 | $35 |
| Rhopressa | 11 | $3,746 | $341 |
| Timolol Maleate | 86 | $3,223 | $37 |
| Fluorometholone | 18 | $1,789 | $99 |
| Brimonidine | 77 | $1,563 | $20 |
| Dorzolamide | 44 | $1,433 | $33 |
| Erythromycin | 58 | $1,088 | $19 |
| Valacyclovir | 15 | $946 | $63 |
| Olopatadine | 57 | $902 | $16 |
| Gatifloxacin | 23 | $794 | $35 |
| Diclofenac | 44 | $710 | $16 |
| Polymyxin B Sul-Trimethoprim | 57 | $688 | $12 |
| Neomycin-Polymyxin-Dexameth | 41 | $534 | $13 |
| Levobunolol | 11 | $503 | $46 |
| Moxifloxacin | 27 | $471 | $17 |
| Bacitracin-Polymyxin | 13 | $179 | $14 |
2019: 19 drugs
| Restasis | 41 | $37,783 | $922 |
| Prednisolone Acetate | 196 | $11,605 | $59 |
| Latanoprost | 447 | $7,580 | $17 |
| Xiidra | 11 | $7,520 | $684 |
| Dorzolamide-Timolol | 123 | $4,452 | $36 |
| Timolol Maleate | 84 | $1,992 | $24 |
| Dexamethasone Sodium Phosphate | 23 | $1,663 | $72 |
| Dorzolamide | 57 | $1,652 | $29 |
| Polymyxin B Sul-Trimethoprim | 134 | $1,591 | $12 |
| Fluorometholone | 12 | $1,365 | $114 |
| Erythromycin | 52 | $1,140 | $22 |
| Neomycin-Polymyxin-Dexameth | 66 | $1,117 | $17 |
| Brimonidine | 66 | $994 | $15 |
| Doxycycline Monohydrate | 18 | $841 | $47 |
| Diclofenac | 50 | $786 | $16 |
| Olopatadine | 34 | $571 | $17 |
| Ketorolac Tromethamine | 16 | $351 | $22 |
| Valacyclovir | 12 | $305 | $25 |
| Levobunolol | 22 | $234 | $11 |
2018: 15 drugs
| Restasis | 51 | $35,594 | $698 |
| Prednisolone Acetate | 220 | $15,973 | $73 |
| Latanoprost | 245 | $5,426 | $22 |
| Zioptan | 14 | $3,196 | $228 |
| Dorzolamide-Timolol | 102 | $2,220 | $22 |
| Fluorometholone | 15 | $1,808 | $121 |
| Polymyxin B Sul-Trimethoprim | 129 | $1,521 | $12 |
| Neomycin-Polymyxin-Dexameth | 60 | $1,125 | $19 |
| Gatifloxacin | 13 | $1,037 | $80 |
| Timolol Maleate | 61 | $813 | $13 |
| Erythromycin | 47 | $811 | $17 |
| Brimonidine | 50 | $741 | $15 |
| Diclofenac | 39 | $503 | $13 |
| Dorzolamide | 13 | $376 | $29 |
| Olopatadine | 26 | $286 | $11 |
2017: 16 drugs
| Restasis | 69 | $39,313 | $570 |
| Prednisolone Acetate | 250 | $17,329 | $69 |
| Latanoprost | 167 | $3,973 | $24 |
| Neomycin-Polymyxin-Dexameth | 139 | $2,642 | $19 |
| Bacitracin | 17 | $2,112 | $124 |
| Fluorometholone | 27 | $1,884 | $70 |
| Fml S.O.P. | 11 | $1,754 | $159 |
| Dorzolamide-Timolol | 70 | $1,635 | $23 |
| Polymyxin B Sul-Trimethoprim | 149 | $1,444 | $10 |
| Timolol Maleate | 47 | $1,280 | $27 |
| Gatifloxacin | 22 | $906 | $41 |
| Erythromycin | 50 | $870 | $17 |
| Diclofenac | 63 | $863 | $14 |
| Brimonidine | 37 | $554 | $15 |
| Dorzolamide | 12 | $286 | $24 |
| Olopatadine | 18 | $233 | $13 |
2016: 13 drugs
| Restasis | 51 | $22,783 | $447 |
| Prednisolone Acetate | 155 | $10,817 | $70 |
| Zymaxid | 114 | $9,142 | $80 |
| Latanoprost | 152 | $3,397 | $22 |
| Lumigan | 12 | $2,193 | $183 |
| Bacitracin | 14 | $1,647 | $118 |
| Timolol Maleate | 50 | $1,573 | $31 |
| Dorzolamide-Timolol | 51 | $1,104 | $22 |
| Neomycin-Polymyxin-Dexameth | 56 | $982 | $18 |
| Brimonidine | 36 | $800 | $22 |
| Diclofenac | 50 | $721 | $14 |
| Erythromycin | 26 | $452 | $17 |
| Dorzolamide | 13 | $279 | $21 |
2015: 14 drugs
| Restasis | 64 | $24,778 | $387 |
| Prednisolone Acetate | 323 | $22,255 | $69 |
| Zymaxid | 234 | $20,472 | $87 |
| Latanoprost | 171 | $3,915 | $23 |
| Bacitracin | 36 | $3,027 | $84 |
| Lumigan | 13 | $2,880 | $222 |
| Neomycin-Polymyxin-Dexameth | 130 | $2,380 | $18 |
| Diclofenac | 136 | $1,986 | $15 |
| Timolol Maleate | 39 | $1,444 | $37 |
| Erythromycin | 55 | $959 | $17 |
| Dorzolamide-Timolol | 42 | $799 | $19 |
| Acyclovir | 15 | $557 | $37 |
| Brimonidine | 18 | $394 | $22 |
| Fluorometholone | 15 | $227 | $15 |
2014: 12 drugs
| Prednisolone Acetate | 385 | $25,563 | $66 |
| Zymaxid | 295 | $25,159 | $85 |
| Restasis | 37 | $14,134 | $382 |
| Lumigan | 13 | $4,809 | $370 |
| Latanoprost | 133 | $2,936 | $22 |
| Diclofenac | 163 | $2,418 | $15 |
| Neomycin-Polymyxin-Dexameth | 104 | $1,882 | $18 |
| Bacitracin | 18 | $1,338 | $74 |
| Dorzolamide-Timolol | 51 | $1,128 | $22 |
| Timolol Maleate | 50 | $1,117 | $22 |
| Erythromycin | 24 | $475 | $20 |
| Brimonidine | 23 | $389 | $17 |
2013: 14 drugs
| Zymaxid | 216 | $15,449 | $72 |
| Restasis | 38 | $12,287 | $323 |
| Prednisolone Acetate | 270 | $9,405 | $35 |
| Tobradex | 22 | $4,211 | $191 |
| Latanoprost | 111 | $2,360 | $21 |
| Neomycin-Polymyxin-Dexameth | 110 | $2,175 | $20 |
| Bacitracin | 16 | $999 | $62 |
| Dorzolamide-Timolol | 30 | $970 | $32 |
| Ketorolac Tromethamine | 38 | $839 | $22 |
| Timolol Maleate | 42 | $674 | $16 |
| Diclofenac | 37 | $549 | $15 |
| Erythromycin | 25 | $495 | $20 |
| Brimonidine | 15 | $368 | $25 |
| Phenylephrine | 12 | $366 | $31 |
Money from drug and device companies
$220 in 2025
| 2025 | 1 | 2 | None | $220 |
| 2024 | 2 | 2 | None | $288 |
| 2023 | 1 | 1 | None | $213 |
| 2022 | 1 | 2 | None | $147 |
| 2019 | 2 | 3 | None | $276 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Hydrus Microstent | $220 | 2 payments
|
See all 2 published payments
| Alcon Vision | Meals · 2025-09-03 | Clareon Panoptix Pro | $75 |
| Alcon Vision | Meals · 2025-07-24 | Hydrus Microstent | $145 |
See earlier years (2024, 2023, 2022, 2019)
2024: $288
| Ocular Therapeutix | Dextenza | $167 | 1 payment
|
| Alcon Vision | Clareon | $121 | 1 payment
|
2023: $213
| Alcon Vision | None | $213 | 1 payment
|
2022: $147
| Alcon Vision | Clareon | $147 | 2 payments
|
2019: $276
| EyePoint Pharmaceuticals US | Dexycu | $173 | 2 payments
|
| Johnson & Johnson Surgical Vision | Catalys Laser System | $103 | 1 payment
|
Professional record
- NPI
- 1508844341
- Licence
- CA A92811California A92811: Current · expires 2027-07-31
- Trained
- New York Medical College, 2000
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1 Gustav Levy Place, Box 1183, New York, NY, 10029
- NPI first listed
- 2006-01-03
- NPI last updated
- 2021-12-20
- NPI record certified
- 2021-12-20
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.